Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 17,096 UPB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| Jun 11, 2026 | Kailera Therapeutics, Inc. (KLRA) | Exercise/Conversion | 38,094 | $200.0K |
| Apr 20, 2026 | Kailera Therapeutics, Inc. (KLRA) | Grant/Award | 300,000 | n/a |
| Jun 12, 2025 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| Oct 15, 2024 | Upstream Bio, Inc. (UPB) | Grant/Award | 17,096 | n/a |
| Jan 23, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 284,023 | n/a |
| Jun 27, 2022 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 20,500 | n/a |
| Jun 13, 2022 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 13,419 | n/a |
| Dec 23, 2021 | Ikena Oncology, Inc. (IKNA) | Grant/Award | 13,419 | n/a |
| Jun 9, 2021 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 11,000 | n/a |